• ENAA

  • Menu
  • Home
  • News
  • About Us
  • Education
  • Countries
  • Conferences
  • Links
  • Login
European Network Adult ADHD
  • Menu
  • Home
  • News
  • About Us
  • Education
    • What is adult ADHD
    • The brain in ADHD
    • Heritability
    • Diagnosis
    • Comorbidity
    • Treatment
    • General Health
  • Countries
  • Conferences
  • Links
    • Login

52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder

CONCLUSIONS: Results from this trial demonstrate that CTN SR 400 mg is safe and effective for long-term treatment of adults with ADHD.

via https://pubmed.ncbi.nlm.nih.gov/40600581/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20250714011006&v=2.18.0.post9+e462414

 

News

  • Clinical Improvement in Adult Patients with Attention-Deficit/Hyperactivity Disorder Under Psychopharmacological Treatment: Influence on Personality Traits and Mind-Wandering
  • Time to Focus on Atypical Sensory Processing in ADHD—Extending the Evidence Into Adulthood.
  • Link between ADHD and Dementia
  • The how and why of our article “Theophrastos’s Obtuse Man: the oldest phenomenological description of Neurodevelopmental Disorder in adult”
  • Experience experts are becoming more and more important

Videos

  • Delineating ADHD and bipolar disorder: A comparison of clinical profiles in adult women
  • ADHD as a fluctuating condition
  • Drive safely! Adults with ADHD keep crashing their vehicles
  • Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/ and autism spectrum disorder (ASD)
  • ADHD as a Risk Factor for Infection With Covid-19

Latest on ADHDPublications

  • Effects of music-based occupational therapy activities on attention executive functions in children with attention deficit and hyperactivity disorder
  • Adaptive stepped care in preschool-age children with ADHD symptoms: a multicentre study including two consecutive randomised controlled trials (ESCApreschool)
  • Dimensional and categorical approaches to behavioral-emotional problems in children and adolescents with mental disorders: A cross-sectional study
  • Systematic review: Efficacy of off-label antipsychotic use in children and adolescents with obsessive-compulsive, mood dysregulation, depression, anxiety, and sleep-related disorders
  • Supporting Decision Making on ADHD Medication: Development and Evaluation of a Decision Aid for Parents

Website by FourLeafed